Procurement Business Partner, ACE Markets: Spain, Portugal & Nordic Markets at Gilead Sciences

Madrid, Community of Madrid, Spain

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Pharmaceutical, Biotechnology, HealthcareIndustries

Requirements

Candidates should have experience in procurement, specifically within the ACE Markets including Spain, Portugal, and Nordic countries. A strong understanding of procurement strategies and supplier relationship management is necessary. Experience in the biopharmaceutical industry is preferred.

Responsibilities

The Procurement Business Partner will partner with key stakeholder groups in Gilead's Iberian Affiliate, supporting the development and implementation of global and local procurement strategies. They will liaise with Global Procurement Category Managers to drive local adoption of global category strategies and optimize spend with local suppliers. The role involves identifying opportunities to optimize spend with suppliers and engaging early with Affiliate teams to achieve these goals.

Skills

Procurement

Business Partnering

Supply Chain Management

Contract Negotiation

Supplier Relationship Management

Market Analysis

Financial Acumen

Cross-functional Collaboration

Stakeholder Management

Risk Management

Spanish

Portuguese

Nordic Languages

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free